Author:
Razanskaite Violeta,Bettey Marion,Downey Louise,Wright Julia,Callaghan James,Rush Miles,Whiteoak Simon,Ker Sarah,Perry Kim,Underhill Caron,Efrem Eren,Ahmed Iftikar,Cummings Fraser
Publisher
Oxford University Press (OUP)
Subject
Gastroenterology,General Medicine
Reference15 articles.
1. European Medicines Agency, Committee for Medicinal Products for Human Use. Assessment Report. 2013. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_Public_assessment_report/human/002778/WC500151490.pdf Accessed February 16, 2016.
2. A Review of CT-P13: An Infliximab Biosimilar
3. A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study
4. A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study
5. Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort
Cited by
128 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献